WBB Securities Sponsors BioCentury’s 2019 Future Leaders Conference
Posted: Apr 4th, 2019In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2019 Future Leaders ConferenceFINRA Announces Michelle Thomas Winner Of National Adjudicatory Council (NAC) Election
Posted: Dec 21st, 2018In: Press ReleasesWBB Securities’ Chief Compliance Officer / Chief Financial Officer, Michelle Thomas, has been elected and confirmed by the Board to the National Adjudicatory Council (NAC).
Read More about FINRA Announces Michelle Thomas Winner Of National Adjudicatory Council (NAC) ElectionWBB Securities Acts as Co-Manager in $20 Million Follow-on Financing for RedHill Biopharma
Posted: Dec 11th, 2018In: Press ReleasesWBB Securities acted as co-manager to a transaction for RedHill Biopharma Ltd. a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal diseases.
Read More about WBB Securities Acts as Co-Manager in $20 Million Follow-on Financing for RedHill BiopharmaWBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 7th, 2018In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Acts as Co-Manager in $52 Million Follow-on Financing for T2 Biosystems
Posted: Jun 5th, 2018In: Press ReleasesWBB Securities acted as co-manager to a transaction for T2 Biosystems, Inc., a manufacturer of next generation, rapid diagnostic equipment.
Read More about WBB Securities Acts as Co-Manager in $52 Million Follow-on Financing for T2 BiosystemsWBB Securities Sponsors BioCentury’s 2018 Future Leaders Conference
Posted: Mar 23rd, 2018In: Press ReleasesWBB Securities is a sponsor of this year’s Future Leader’s conference.
Read More about WBB Securities Sponsors BioCentury’s 2018 Future Leaders ConferenceWBB Securities Asset Management Receives Hedgeweek Award For Life Sciences Investing
Posted: Sep 22nd, 2017In: Press ReleasesWBB Securities, LLC is pleased to announce that the WBB Asset Management Long/Short Life Science Strategy (LSLSS) was the recipient of Hedgeweek USA’s 2017 Award for Best Event Driven Strategy last night in New York[...]
Read More about WBB Securities Asset Management Receives Hedgeweek Award For Life Sciences InvestingWBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 Biosystems
Posted: Sep 21st, 2017In: Press ReleasesWBB Securities acted as co-manager to a transaction for T2 Biosystems, Inc., a manufacturer of next generation, rapid diagnostic equipment.
Read More about WBB Securities Acts as Co-Manager in $17 Million Follow-on Financing for T2 BiosystemsWBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Posted: Sep 8th, 2017In: Press ReleasesWBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.
Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers ConferenceWBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.
Posted: May 31st, 2017In: Press ReleasesWBB Securities acted as co-manager to a transaction for Corium International, Inc., a commercial stage developer of transdermal healthcare products.
Read More about WBB Securities Acts as Co-Manager in $40 Million Follow-on Financing for Corium International, Inc.